Sign in
CompletedNo phase

Impact of Sleep Related Breathing Disorders on Outcomes of Acute Pulmonary Embolism

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
1 Jan 2025
Ended
1 Jan 2026
Type of study
Observational
Treatments tested
  • polysomnography
Record updated
21 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Age≥18years; Objectively confirmed acute pulmonary embolism by computed tomography pulmonary angiography (CTPA); Hemodynamically stable or clinically stabilized within 72 hours of admission. .Ability to provide informed consent

Who cannot take part

  • .Known central sleep apnea without obstructive features. .Inabilityto undergo sleep study evaluation
  • Pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aimsto compare short-termclinical outcomesand one-year recurrence rates in patients with acute pulmonary embolism with versus without sleep-disordered breathing, recruited from Alexandria MainUniversityHospital.

Treatments tested

  • polysomnography

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Short- Term Outcome and One -Year Recurrence in Acute Pulmonary Embolism Patients With and Without Sleep - Disordered Breathing
Record updated
21 January 2026